Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

ClinicalTrials.gov ID: NCT00035269

Public ClinicalTrials.gov record NCT00035269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Linezolid in the Treatment of Penicillin-Resistant Streptococcus Pneumoniae Pneumonia: An Open-Label, Non-Comparator Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will treat patients who have a community-acquired pneumonia that is due to a specific bacteria (S. pneumoniae)

Study identification

NCT ID
NCT00035269
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
230 participants

Conditions and interventions

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2001 (Type not available)
Primary completion
Not listed
Completion
May 2003 (Actual)
Last update posted
Apr 26, 2011

2001 – 2003

United States locations

U.S. sites
34
U.S. states
17
U.S. cities
32
Facility City State ZIP Site status
Research Center Los Angeles California 90033 —
Research Center Jacksonville Florida 32209 —
Research Center Naples Florida 34102 —
Research Center Savannah Georgia 31416 —
Research Center Springfield Illinois 62701 —
Research Center Baton Rouge Louisiana 70808 —
Research Center Baltimore Maryland 21201 —
Research Center Ann Arbor Michigan 48197 —
Research Center Royal Oak Michigan 48073 —
Research Center Springfield Missouri 65807 —
Research Center Hackensack New Jersey 07601 —
Research Center Newark New Jersey 07102 —
Research Center Somerville New Jersey 08876 —
Research Center Staten Island New York 10305 —
Research Center Stony Brook New York 11794 —
Research Center Columbus Ohio 43215 —
Research Center Zanesville Ohio 43701 —
Research Center Fleetwood Pennsylvania 19522 —
Research Center Hershey Pennsylvania 17033 —
Research Center Ninety Six South Carolina 29666 —
Research Center Spartanburg South Carolina 29307 —
Research Center Harrogate Tennessee 37752-0078 —
Research Center Jackson Tennessee 38301 —
Research Center Knoxville Tennessee 37920 —
Research Center Memphis Tennessee 38104-3499 —
Research Center Memphis Tennessee 38120 —
Research Center Memphis Tennessee 38163 —
Research Center Nashville Tennessee 37205 —
Research Center Dallas Texas 75235 —
Research Center Houston Texas 77030 —
Research Center Lubbock Texas 79430 —
Research Center Charlottesville Virginia 22902 —
Research Center Richmond Virginia 23294 —
Research Center Seattle Washington 98108 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00035269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2011 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00035269 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →